Optimizing the Manufacture of Emerging Therapies: Guidance for GMP manufacture of emerging therapies has evolved to accommodate innovation and the broader spectrum of products in development, but greater harmonization is still needed...Elena Meurer
| Published in: | Pharmaceutical Technology Europe Vol. 35; no. 5; pp. 31 - 34 |
|---|---|
| Main Author: | |
| Format: | interview pictorial Journal Article |
| Published: |
MJH Life Sciences
May2023
|
| Online Access: | View this record in EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=163834947&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 163834947 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 17537967 5NG jtl: Pharmaceutical Technology Europe issn: 17537967 maglogo: N pubinfo: dt: May2023 vid: 35 iid: 5 pid: 54670 pub: MJH Life Sciences place: Cranbury, New Jersey artinfo: ui: 163834947 163834947 163834947 163834947 ppf: 31 ppct: 3 formats: fmt: @attributes: type: P tig: atl: Optimizing the Manufacture of Emerging Therapies: Guidance for GMP manufacture of emerging therapies has evolved to accommodate innovation and the broader spectrum of products in development, but greater harmonization is still needed...Elena Meurer aug: au: Thomas, Felicity sug: subj: Pharmaceutical Companies Standards Manufacturing Industry Standards Diffusion of Innovation Government Regulations Drugs, Investigational Biological Products Patient Safety Quality of Health Care Standards Health Services Needs and Demand pubtype: Trade Publication doctype: interview pictorial Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|